This contract award to Organogenesis Inc., a leading regenerative medicine company, provides the Defense Logistics Agency (DLA) Troop Support Medical with advanced wound care products, including skin substitutes, wound matrices, and tissue regeneration solutions. The $2,479.90 fixed-price delivery order falls under Organogenesis' $49.5 million multiple-award Indefinite Delivery Contract (IDC) with the DLA for wound care dressings and medical supplies, which runs from June 2021 to June 2026. Organogenesis also holds several other significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and the DLA, demonstrating its strong presence in government medical procurement. The delivery order does not utilize a set-aside designation, as Organogenesis is a for-profit organization and manufacturer of goods. This contract supports the medical supply chain needs of the Department of Defense (DoD) and VA, providing specialized products designed to aid wound healing and tissue regeneration for service members and veterans.
Generated 2/13/25, 9:18 AM